{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:34:47Z","timestamp":1786995287983,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009613","name":"Centro de Investigaciones Energ\u00e9ticas Medioambientales y Tecnol\u00f3gicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009613","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009613","name":"Centro de Investigaciones Energ\u00e9ticas Medioambientales y Tecnol\u00f3gicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009613","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.omtm.2021.05.001","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:26:07Z","timestamp":1620944767000},"page":"237-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Clinically relevant gene editing in hematopoietic stem cells for the treatment of pyruvate kinase deficiency"],"prefix":"10.1016","volume":"22","author":[{"given":"Sara","family":"Fa\u00f1anas-Baquero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Quintana-Bustamante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Dever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omaira","family":"Alberquilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Sanchez-Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joab","family":"Camarena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Ojeda-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Dessy-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Turk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mollie S.","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Lattanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L.","family":"Lopez-Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"Bueren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Behlke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Porteus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose-Carlos","family":"Segovia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2021.05.001_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bcmd.2015.12.009","article-title":"Red blood cell PK deficiency: An update of PK-LR gene mutation database","volume":"57","author":"Canu","year":"2016","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.omtm.2021.05.001_bib2","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1182\/blood-2017-10-810796","article-title":"Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study","volume":"131","author":"Grace","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.05.001_bib3","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/mt.2009.200","article-title":"Rescue of pyruvate kinase deficiency in mice by gene therapy using the human isoenzyme","volume":"17","author":"Meza","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.05.001_bib4","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1182\/blood.2019000945","article-title":"Management of pyruvate kinase deficiency in children and adults","volume":"136","author":"Grace","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.05.001_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/jp.2009.118","article-title":"Pyruvate kinase deficiency as a cause of extreme hyperbilirubinemia in neonates from a polygamist community","volume":"30","author":"Christensen","year":"2010","journal-title":"J.\u00a0Perinatol."},{"key":"10.1016\/j.omtm.2021.05.001_bib6","first-page":"634","article-title":"Erythrocyte pyruvate kinase deficiency in the Ohio Amish: origin and characterization of the mutant enzyme","volume":"36","author":"Muir","year":"1984","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2021.05.001_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.blre.2007.01.001","article-title":"Pyruvate kinase deficiency: the genotype-phenotype association","volume":"21","author":"Zanella","year":"2007","journal-title":"Blood Rev."},{"key":"10.1016\/j.omtm.2021.05.001_bib8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3324\/haematol.2019.238865","article-title":"AG-348 (Mitapivat), an allosteric activator of red blood cell pyruvate kinase, increases enzymatic activity, protein stability, and ATP levels over a broad range of PKLR genotypes","volume":"106","author":"Rab","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.omtm.2021.05.001_bib9","doi-asserted-by":"crossref","first-page":"e0028","DOI":"10.5041\/RMMJ.10162","article-title":"Hematopoietic stem cell transplantation-50 years of evolution and future perspectives","volume":"5","author":"Henig","year":"2014","journal-title":"Rambam Maimonides Med. J."},{"key":"10.1016\/j.omtm.2021.05.001_bib10","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/bjh.14165","article-title":"Four decades of stem cell transplantation for Fanconi anaemia in the Netherlands","volume":"174","author":"Smetsers","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omtm.2021.05.001_bib11","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.3324\/haematol.2017.177857","article-title":"Worldwide study of hematopoietic allogeneic stem cell transplantation in pyruvate kinase deficiency","volume":"103","author":"van Straaten","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.omtm.2021.05.001_bib12","doi-asserted-by":"crossref","first-page":"eaan4672","DOI":"10.1126\/science.aan4672","article-title":"Gene therapy comes of age","volume":"359","author":"Dunbar","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.omtm.2021.05.001_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/cge.13593","article-title":"Advances in the gene therapy of monogenic blood cell diseases","volume":"97","author":"Bueren","year":"2020","journal-title":"Clin. Genet."},{"key":"10.1016\/j.omtm.2021.05.001_bib14","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1056\/NEJMoa1705342","article-title":"Gene therapy in patients with transfusion-dependent \u03b2-thalassemia","volume":"378","author":"Thompson","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2021.05.001_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","article-title":"Transfusion independence and HMGA2 activation after gene therapy of human \u03b2-thalassaemia","volume":"467","author":"Cavazzana-Calvo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2021.05.001_bib16","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41591-018-0301-6","article-title":"Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent \u00df-thalassemia","volume":"25","author":"Marktel","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2021.05.001_bib17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJMoa1609677","article-title":"Gene therapy in a patient with sickle cell disease","volume":"376","author":"Ribeil","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2021.05.001_bib18","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/mt.2016.87","article-title":"Safe and efficient gene therapy for pyruvate kinase deficiency","volume":"24","author":"Garcia-Gomez","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.05.001_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1182\/blood-2020-137246","article-title":"Lentiviral Mediated Gene Therapy for Pyruvate Kinase Deficiency: A Global Phase 1 Study for Adult and Pediatric Patients","volume":"136","author":"L\u00f3pez Lorenzo","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.05.001_bib20","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ymthe.2019.03.007","article-title":"Clinically Relevant Correction of Recessive Dystrophic Epidermolysis Bullosa by Dual sgRNA CRISPR\/Cas9-Mediated Gene Editing","volume":"27","author":"Bonafont","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.05.001_bib21","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1038\/s41467-018-07827-1","article-title":"CRISPR\/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I","volume":"9","author":"Zabaleta","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2021.05.001_bib22","doi-asserted-by":"crossref","first-page":"16007","DOI":"10.1038\/ncomms16007","article-title":"Muscle-specific CRISPR\/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy","volume":"8","author":"Bengtsson","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2021.05.001_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature13420","article-title":"Targeted genome editing in human repopulating haematopoietic stem cells","volume":"510","author":"Genovese","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2021.05.001_bib24","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature20134","article-title":"CRISPR\/Cas9 \u03b2-globin gene targeting in human haematopoietic stem cells","volume":"539","author":"Dever","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2021.05.001_bib25","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41591-018-0137-0","article-title":"A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells","volume":"24","author":"Vakulskas","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2021.05.001_bib26","doi-asserted-by":"crossref","first-page":"eaah3480","DOI":"10.1126\/scitranslmed.aah3480","article-title":"CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease","volume":"9","author":"De Ravin","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2021.05.001_bib27","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nbt.3513","article-title":"Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous disease","volume":"34","author":"De Ravin","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2021.05.001_bib28","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.15252\/emmm.201707540","article-title":"Therapeutic gene editing in CD34+ hematopoietic progenitors from Fanconi anemia patients","volume":"9","author":"Diez","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtm.2021.05.001_bib29","doi-asserted-by":"crossref","first-page":"835","DOI":"10.15252\/emmm.201303374","article-title":"Targeted gene therapy and cell reprogramming in Fanconi anemia","volume":"6","author":"Rio","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtm.2021.05.001_bib30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1126\/science.1242088","article-title":"A erythroid enhancer of BCL11A subject to genetic variation","volume":"342","author":"Bauer","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.omtm.2021.05.001_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.omtm.2016.12.009","article-title":"Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing in Bone-Marrow-Derived CD34+ Hematopoietic Stem and Progenitor Cells","volume":"4","author":"Chang","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2021.05.001_bib32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.omtm.2018.08.003","article-title":"Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with \u03b2-Thalassemia Major","volume":"10","author":"Psatha","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2021.05.001_bib33","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41591-019-0401-y","article-title":"Highly efficient therapeutic gene editing of human hematopoietic stem cells","volume":"25","author":"Wu","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2021.05.001_bib34","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 Gene Editing for Sickle Cell Disease and \u03b2-Thalassemia","volume":"384","author":"Frangoul","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2021.05.001_bib35","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.stemcr.2015.10.002","article-title":"Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells","volume":"5","author":"Garate","year":"2015","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.omtm.2021.05.001_bib36","doi-asserted-by":"crossref","first-page":"e0223775","DOI":"10.1371\/journal.pone.0223775","article-title":"Gene editing of PKLR gene in human hematopoietic progenitors through 5 \u2019 and 3 \u2019 UTR modified TALEN mRNA","volume":"14","author":"Quintana-Bustamante","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2021.05.001_bib37","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.stem.2019.02.019","article-title":"Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response","volume":"24","author":"Schiroli","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtm.2021.05.001_bib38","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.omtm.2020.04.027","article-title":"Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant System","volume":"17","author":"Shapiro","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2021.05.001_bib39","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1182\/blood-2015-11-683235","article-title":"Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome","volume":"127","author":"Hubbard","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.05.001_bib40","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/nar\/gkt947","article-title":"Nuclease-mediated gene editing by homologous recombination of the human globin locus","volume":"42","author":"Voit","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2021.05.001_bib41","doi-asserted-by":"crossref","first-page":"34531","DOI":"10.1038\/srep34531","article-title":"Increasing the Efficiency of CRISPR\/Cas9-mediated Precise Genome Editing of HSV-1 Virus in Human Cells","volume":"6","author":"Lin","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2021.05.001_bib42","first-page":"538","article-title":"Inhibition of non-homologous end joining increases the efficiency of CRISPR\/Cas9-mediated precise genome editing","volume":"33","author":"Maruyama","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2021.05.001_bib43","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1182\/blood.2020008503","article-title":"Enhanced Homology-directed Repair for Highly Efficient Gene Editing in Hematopoietic Stem\/Progenitor Cells","volume":"137","author":"De Ravin","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.05.001_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41434-021-00251-z","article-title":"Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR\/Cas9 with 53BP1 inhibition for enhanced homology-directed repair","author":"Sweeney","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2021.05.001_bib45","doi-asserted-by":"crossref","first-page":"10548","DOI":"10.1038\/ncomms10548","article-title":"RS-1 enhances CRISPR\/Cas9- and TALEN-mediated knock-in efficiency","volume":"7","author":"Song","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2021.05.001_bib46","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","article-title":"CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response","volume":"24","author":"Haapaniemi","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2021.05.001_bib47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nature25154","article-title":"Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells","volume":"553","author":"Garaycoechea","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2021.05.001_bib48","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/gt.2010.163","article-title":"Quantification of lentiviral vector copy numbers in individual hematopoietic colony-forming cells shows vector dose-dependent effects on the frequency and level of transduction","volume":"18","author":"Charrier","year":"2011","journal-title":"Gene Ther."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121000851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121000851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:27:30Z","timestamp":1762421250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050121000851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":48,"alternative-id":["S2329050121000851"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2021.05.001","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.01.14.426673","asserted-by":"object"}]},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinically relevant gene editing in hematopoietic stem cells for the treatment of pyruvate kinase deficiency","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2021.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}]}}